728 related articles for article (PubMed ID: 15588425)
1. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
[TBL] [Abstract][Full Text] [Related]
3. IFNs activate toll-like receptor gene expression in viral infections.
Miettinen M; Sareneva T; Julkunen I; Matikainen S
Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
[TBL] [Abstract][Full Text] [Related]
4. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
Nishiya T; DeFranco AL
J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
[TBL] [Abstract][Full Text] [Related]
6. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
7. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
9. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of Toll-like receptors in chicken heterophils.
Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide.
Hijiya N; Miyake K; Akashi S; Matsuura K; Higuchi Y; Yamamoto S
Pathobiology; 2002; 70(1):18-25. PubMed ID: 12415188
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M; Voelcker V; Köllisch G; Plank C; Rad R; Gerhard M; Schnopp C; Fraunberger P; Walli AK; Ring J; Abeck D; Ollert M
J Invest Dermatol; 2003 Dec; 121(6):1389-96. PubMed ID: 14675188
[TBL] [Abstract][Full Text] [Related]
14. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors as adjuvant receptors.
Kaisho T; Akira S
Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
[TBL] [Abstract][Full Text] [Related]
16. TLRs govern neutrophil activity in aspergillosis.
Bellocchio S; Moretti S; Perruccio K; Fallarino F; Bozza S; Montagnoli C; Mosci P; Lipford GB; Pitzurra L; Romani L
J Immunol; 2004 Dec; 173(12):7406-15. PubMed ID: 15585866
[TBL] [Abstract][Full Text] [Related]
17. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
Mishra BB; Mishra PK; Teale JM
J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish.
Meijer AH; Gabby Krens SF; Medina Rodriguez IA; He S; Bitter W; Ewa Snaar-Jagalska B; Spaink HP
Mol Immunol; 2004 Jan; 40(11):773-83. PubMed ID: 14687934
[TBL] [Abstract][Full Text] [Related]
19. Ethanol suppresses cytokine responses induced through Toll-like receptors as well as innate resistance to Escherichia coli in a mouse model for binge drinking.
Pruett SB; Zheng Q; Fan R; Matthews K; Schwab C
Alcohol; 2004 Jun; 33(2):147-55. PubMed ID: 15528012
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7.
Lee J; Chuang TH; Redecke V; She L; Pitha PM; Carson DA; Raz E; Cottam HB
Proc Natl Acad Sci U S A; 2003 May; 100(11):6646-51. PubMed ID: 12738885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
